Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ:ARTV
US Market
Holding ARTV?
Track your performance easily

Artiva Biotherapeutics, Inc. (ARTV) Financial Statements

11 Followers

Artiva Biotherapeutics, Inc. Financial Overview

Artiva Biotherapeutics, Inc.'s market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Artiva Biotherapeutics, Inc. is scheduled to report earnings on August 29, 2024, and the estimated EPS forecast is $-1.38. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Dec 22
Income Statement-
Total Revenue$ 251.00K--
Gross Profit$ 251.00K--
EBIT$ -13.96M--
EBITDA$ -13.38M--
Net Income Common Stockholders$ -13.96M--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 62.13M$ 76.97M$ 102.53M
Total Assets$ 90.16M$ 105.11M$ 133.05M
Total Debt$ 16.26M$ 16.91M$ 19.45M
Net Debt$ -45.88M$ -60.06M$ -83.08M
Total Liabilities$ 48.42M$ 50.72M$ 57.34M
Stockholders Equity$ 41.74M$ 54.40M$ 75.72M
Cash Flow-
Free Cash Flow$ -15.10M--
Operating Cash Flow$ -15.09M--
Investing Cash Flow$ 9.78M--
Financing Cash Flow---
Currency in USD

Artiva Biotherapeutics, Inc. Earnings and Revenue History

Artiva Biotherapeutics, Inc. Debt to Assets

Artiva Biotherapeutics, Inc. Cash Flow

Artiva Biotherapeutics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis